Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study

In patients with resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma, surgery plus perioperative platinum-based chemotherapy is the standard of care. Perioperative chemotherapy remains debatable for gastric/GEJ adenocarcinoma with deficient mismatch repair (dMMR)/microsatellite instabi...

Descripción completa

Detalles Bibliográficos
Autores principales: André, Thierry, Tougeron, David, Piessen, Guillaume, de la Fouchardière, Christelle, Louvet, Christophe, Adenis, Antoine, Jary, Marine, Tournigand, Christophe, Aparicio, Thomas, Desrame, Jérôme, Lièvre, Astrid, Garcia-Larnicol, Marie-Line, Pudlarz, Thomas, Cohen, Romain, Memmi, Salomé, Vernerey, Dewi, Henriques, Julie, Lefevre, Jérémie H., Svrcek, Magali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839243/
https://www.ncbi.nlm.nih.gov/pubmed/35969830
http://dx.doi.org/10.1200/JCO.22.00686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839243/
https://www.ncbi.nlm.nih.gov/pubmed/35969830
http://dx.doi.org/10.1200/JCO.22.00686

Ejemplares similares